NASDAQ: SRDXSurmodics Revenue
Surmodics revenue was $121.58M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $28.1M, down 6.1% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, SRDX annual revenue was $126.1M, with -4.9% growth year-over-year.
SRDX past revenue growth
How has SRDX's revenue growth performed historically?
Company
-14.96%
Industry
10.39%
Market
34.96%
SRDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SRDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SRDX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
SRDX revenue history
Current Revenue
$121.6M
Current Earnings
-$19.9M
Current Profit Margin
-16.3%
Be the first to know when SRDX announces revenue.
SRDX Revenue History By Year
| SRDX Yearly Revenue | SRDX Revenue | SRDX Change | SRDX Revenue Growth |
|---|---|---|---|
| 2024-09-30 | $126.08M | -$6.51M | -4.91% |
| 2023-09-30 | $132.58M | $32.63M | +32.65% |
| 2022-09-30 | $99.95M | -$5.19M | -4.93% |
| 2021-09-30 | $105.14M | $10.27M | +10.83% |
| 2020-09-30 | $94.86M | -$5.21M | -5.21% |
| 2019-09-30 | $100.08M | $18.74M | +23.04% |
| 2018-09-30 | $81.34M | $8.22M | +11.25% |
| 2017-09-30 | $73.11M | $1.75M | +2.45% |
| 2016-09-30 | $71.37M | $9.47M | +15.30% |
| 2015-09-30 | $61.90M | $4.46M | +7.76% |
| 2014-09-30 | $57.44M | $1.31M | +2.33% |
| 2013-09-30 | $56.13M | $4.20M | +8.10% |
| 2012-09-30 | $51.93M | -$828.00k | -1.57% |
| 2011-09-30 | $52.76M | -$1.73M | -3.18% |
| 2010-09-30 | $54.49M | -$67.05M | -55.17% |
| 2009-09-30 | $121.53M | $24.48M | +25.23% |
| 2008-09-30 | $97.05M | $23.89M | +32.65% |
| 2007-09-30 | $73.16M | $3.28M | +4.69% |
| 2006-09-30 | $69.88M | $7.50M | +12.03% |
| 2005-09-30 | $62.38M | $12.64M | +25.42% |
| 2004-09-30 | $49.74M | $6.51M | +15.05% |
| 2003-09-30 | $43.23M | $13.74M | +46.61% |
| 2002-09-30 | $29.49M | $6.80M | +29.94% |
| 2001-09-30 | $22.69M | $4.41M | +24.15% |
| 2000-09-30 | $18.28M | $4.79M | +35.46% |
| 1999-09-30 | $13.49M | $3.72M | +37.99% |
| 1998-09-30 | $9.78M | $2.20M | +28.98% |
| 1997-09-30 | $7.58M | $1.40M | +22.63% |
| 1996-09-30 | $6.18M | N/A | N/A |
Surmodics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.